RTOG 0625: A phase II study of bevacizumab with irinotecan in recurrent glioblastoma (GBM) Meeting Abstract


Authors: Gilbert, M. R.; Wang, M.; Aldape, K.; Lassman, A.; Sorensen, A. G.; Mikkelson, T.; Groves, M.; Werner-Wasik, M.; Regine, W.; Mehta, M.
Abstract Title: RTOG 0625: A phase II study of bevacizumab with irinotecan in recurrent glioblastoma (GBM)
Meeting Title: 45th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 27
Issue: 15 Suppl.
Meeting Dates: 2009 May 29-Jun 2
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2009-05-20
Start Page: 89s
Language: English
ACCESSION: WOS:000276606602159
PROVIDER: wos
DOI: 10.1200/jco.2009.27.15_suppl.2011
Notes: Meeting Abstract: 2011 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrew Lassman
    111 Lassman